Tamar Thompson, Director at Avidity Biosciences, Inc. (RNA), sold 30,000 shares at $44.98 ($1.3M) on 2024-10-07, disclosed to the SEC on 2024-10-09.
Open-market sale of $1.3M RNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.